Home / Courses / COUN5261
Capella University — Counseling Program

COUN5261: Interventions for Substance-Related and Addictive Disorders

A complete guide to Capella's COUN5261 — CBT for addiction, motivational enhancement therapy, contingency management, medication-assisted treatment, integrated dual-diagnosis treatment, relapse prevention interventions, and expert help.

Graduate Level Addiction Counseling Evidence-Based SUD Interventions APA 7th Edition

COUN5261 moves from addiction theory (covered in COUN5260) to applied intervention. The course examines the evidence-based treatment approaches that research has shown to be effective for substance use disorders — cognitive-behavioral therapy, motivational enhancement therapy, contingency management, twelve-step facilitation, medication-assisted treatment, and integrated treatment for co-occurring mental health and substance use disorders. Understanding these interventions at the level required to apply them clinically is the competency this course develops.

What COUN5261 covers

Cognitive-behavioral therapy for substance use disorders applies CBT's core model — that cognitions drive emotions and behavior — to the specific cognitive distortions that maintain addictive behavior. Common substance-related cognitive distortions include permission-giving thoughts ("I've had a hard week, I deserve a drink"), catastrophizing about recovery ("I can't handle stress without using"), and underestimating risk ("I can have just one"). The CBT approach includes functional analysis of substance use (identifying the triggers, thoughts, feelings, and consequences that make up the use cycle), cognitive restructuring of substance-related beliefs, coping skills training for managing triggers and cravings without use, and behavioral strategies for avoiding high-risk situations. CBT has extensive research support for alcohol, cocaine, methamphetamine, and cannabis use disorders.

Motivational enhancement therapy (MET) adapts motivational interviewing into a structured, typically four-session intervention format. MET was one of three evidence-based treatments tested in Project MATCH and produced outcomes comparable to twelve sessions of CBT and twelve sessions of TSF — establishing that a brief, motivationally focused intervention can be as effective as longer treatments for many clients with alcohol use disorder. MET is particularly appropriate for clients in early stages of change (pre-contemplation and contemplation) and for engagement in treatment settings where attendance is inconsistent.

Medication-assisted treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies. For opioid use disorder, buprenorphine (Suboxone), methadone, and naltrexone (Vivitrol) are the three approved medication options. For alcohol use disorder, naltrexone, acamprosate (Campral), and disulfiram (Antabuse) are approved. SAMHSA recognizes MAT as the standard of care for opioid use disorder, and counselors must understand how MAT works, what the counselor's role is alongside medication management, and how to address client and community stigma that may create barriers to MAT engagement.

Key topics you write about in COUN5261

Common writing assignments in COUN5261

Evidence-based intervention application paper

Students select an evidence-based SUD intervention (CBT, MET, CM, TSF, or MAT) and apply it to a specific case study client. The paper describes the intervention's theoretical basis, applies its specific techniques to the client's presenting concerns and stage of change, identifies what makes this intervention appropriate for this particular client (substance type, severity, motivation level, co-occurring conditions), and discusses the research evidence supporting its use. Papers that describe the intervention without applying it to the specific client are not clinical application papers.

Integrated treatment plan for co-occurring disorders

Students develop a treatment plan for a client with co-occurring SUD and mental health disorders — substance use disorder alongside depression, PTSD, anxiety, bipolar disorder, or schizophrenia. The plan addresses both disorders simultaneously (integrated treatment model) rather than sequentially, identifies which treatment approaches address both conditions, specifies how MAT and psychotropic medication management are coordinated, and addresses the treatment engagement challenges specific to dual-diagnosis populations. Treatment plans that address SUD and mental health as separate problems treated independently do not reflect the integrated treatment standard.

Discussion posts

Posts address intervention scenarios: a client with opioid use disorder who refuses MAT based on the belief that "taking medication is just substituting one drug for another," a client who has been abstinent for six months and presents with increasingly severe depression, a clinical scenario requiring determination of appropriate ASAM level of care, or a client who insists on moderation management rather than abstinence for a severe alcohol use disorder.

Need help with your COUN5261 intervention application or integrated treatment plan?

Our addiction counseling writers apply CBT, MET, MAT, and integrated treatment approaches to specific client cases with the evidence-based precision Capella's rubric requires.

Get Expert Help

Writing tips for COUN5261

Match intervention to client, not preference

The strongest COUN5261 intervention application papers justify why a specific intervention is appropriate for a specific client based on the evidence base and client characteristics, not based on the student's personal preference or theoretical orientation. CBT is most strongly supported for clients with moderate-severity SUD who have cognitive capacity for self-monitoring and homework. MET is most appropriate for ambivalent clients in early stages of change. Contingency management has the strongest evidence for stimulant use disorders where no effective medication exists. TSF is most appropriate for clients willing to engage with 12-step philosophy. MAT is the standard of care for opioid use disorder regardless of severity. The choice of intervention should follow from the clinical assessment, not precede it.

Address MAT stigma directly in treatment planning

Papers discussing MAT for opioid use disorder should address the stigma barrier directly. Many clients, family members, and even treatment professionals hold the belief that MAT "just replaces one addiction with another." This misunderstanding confuses physical dependence (a neuroadaptation that occurs with many medications, including antidepressants and blood pressure medications) with addiction (compulsive use despite harm). MAT medications stabilize brain chemistry, reduce cravings, and prevent withdrawal, allowing the client to engage in counseling and rebuild their life. Addressing this distinction in treatment planning writing demonstrates the knowledge base COUN5261 builds and the clinical communication skills addiction counselors need.

How GradeEssays helps with COUN5261

GradeEssays supports addiction counseling students in COUN5261 with intervention application papers, integrated treatment plans, and evidence-based SUD intervention writing. When you share your case scenario, intervention focus, and Capella's rubric, your writer produces clinically applied, evidence-grounded addiction intervention writing at the graduate level. All work is original and delivered with time for your review.

Get Help With COUN5261

Intervention applications, integrated treatment plans, MAT analyses, ASAM placement, relapse prevention. Share your case and rubric for evidence-based addiction intervention writing.

Place Your Order View All Services

Related courses

Frequently asked questions

What is cognitive-behavioral therapy for substance use disorders?

CBT for SUD applies the cognitive-behavioral model to the maintenance of addictive behavior. It includes four core components: functional analysis (mapping the triggers, thoughts, emotions, and consequences of each substance use episode to identify the specific patterns maintaining use for this client), cognitive restructuring (identifying and challenging the substance-related thoughts that give permission for use, minimize risk, or catastrophize about recovery), coping skills training (developing specific behavioral and cognitive strategies for managing triggers, cravings, and high-risk situations without using), and behavioral homework (practicing new coping strategies in real-world situations between sessions). CBT for SUD typically runs 12 to 16 sessions and is one of the most extensively researched psychosocial treatments for substance use disorders, with evidence supporting its effectiveness for alcohol, cocaine, methamphetamine, and cannabis use disorders.

What is medication-assisted treatment (MAT) and what is the counselor's role?

MAT combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. For opioid use disorder, the three approved medications are buprenorphine (a partial opioid agonist that reduces cravings and withdrawal), methadone (a full opioid agonist used in federally regulated clinics), and naltrexone (an opioid antagonist that blocks opioid effects). Counselors do not prescribe medications, but their role in MAT is critical: providing the psychosocial treatment component (CBT, MI, contingency management), addressing barriers to medication adherence, managing the therapeutic relationship, supporting recovery beyond medication, and helping clients process stigma about taking medication for addiction. SAMHSA considers MAT the standard of care for opioid use disorder and has identified it as an effective treatment for alcohol use disorder as well. Counselors who work in addiction treatment settings must understand MAT and be prepared to collaborate with prescribing providers.

What is contingency management and when is it used?

Contingency management (CM) is a behavioral intervention that provides tangible reinforcement (vouchers exchangeable for goods or services, or chances to win prizes) contingent on evidence of a desired behavior — typically a negative urine drug screen. CM is grounded in operant conditioning: it reinforces abstinence with immediate, tangible rewards that compete with the delayed rewards of substance use. CM has the strongest evidence base of any psychosocial intervention for stimulant use disorders (cocaine and methamphetamine), where no effective medication exists. Despite this strong evidence, CM has been underutilized in community treatment settings because of ethical concerns about "paying people to be sober," cost, and clinician discomfort with behavioral approaches. In 2024, CMS approved contingency management as a covered benefit through certain Medicaid programs, signaling growing acceptance of its evidence-based effectiveness.

What is integrated treatment for co-occurring disorders?

Integrated treatment addresses substance use disorder and mental health disorder simultaneously within the same treatment program, by the same treatment team, using interventions that target both conditions. This contrasts with the sequential model (treat one disorder first, then the other) and the parallel model (treat both simultaneously but in separate programs with separate clinicians). SAMHSA's integrated treatment model is the evidence-based standard because co-occurring disorders interact: untreated depression drives substance use relapse; active substance use worsens anxiety and PTSD symptoms; separate treatment programs often give contradictory advice. Integrated treatment uses stage-wise interventions matched to the client's readiness for change on each disorder, motivational-based engagement for both conditions, and pharmacotherapy coordination between psychiatric and addiction medications.